MEDICAL PRODUCTS
Human Ultracell V IM
Human Ultracell V Oral
Human Citoplacell 3G
Revercell 3G
Cellorgane Multi-Complex 3G
Androcell 3G
Biofemin 3G
Bioenzym 3G
Celltox 3G
Mekenz H7 3G
Cellorgane Man
Cellorgane Woman
Formula 1 Skin & Muscle
Formula 2 Liver
Formula 3 Heart-Artery-Vein
Formula 4 Bone-Cartilage
Formula 5 Kidney - Nephrons
Formula 6 Lungs
Formula 7 Brain-Hypothalamus-Pituitary
Formula 8 Adrenal Gland
Formula 9 Thymus - Spleen
Formula 10 Pancreas
Formula 11 Esophagus-Stomach-Intestines
Formula 12 Thyroid
LOGGED IN
No one logged in.

Protocols:Type II Diabetes Mellitus (Simple)

Endocrinologists, Internists and General Medicine

Diabetes mellitus (DM) is a group of lifelong metabolic diseases affecting different organs and tissues characterized by an increase in blood glucose levels: hyperglycemia. It is caused by several disorders, the main one being low production of the hormone insulin secreted by the β cells of the islets of Langerhans of the endocrine pancreas, or by inadequate use of the hormone by a part of the body, affecting metabolism of carbohydrates, lipids and proteínas. Diabetes mellitus and its comorbid conditions constitute the primary threat to public health at this time.

The primary symptoms of diabetes mellitus are frequent urination (polyuria), increased appetite (polyphagia), excessive thirst (polydipsia) and unexplained weight loss. Sometimes these three symptoms together (polyuria, polyphagia and polydipsia, or the 3 Ps) are taken as an indication to suspect type 2 diabetes since they are the most common among the population.

The World Health Organization recognized three types of diabetes mellitus: type 1, type 2 and gestational diabetes (occurs during pregnancy), each with different causes and rates of occurrence.

In the year 2000, it was estimated that around 171 million people were diabetic worldwide and that this number would reach 370 million by 2030. This ailment causes various complications, frequently including damage to the eyes, kidneys, nerves and blood vessels.

Its acute complications (hypoglycemia, ketoacidosis, hyperosmolar non-ketotic coma) are consequences of inadequate management of the disease, while its chronic complications (cardiovascular, nephropathy, retinopahty, neuropathy and microvascular damage) are consequences of the disease's progression.

Protocol 1 (Mild Diabetes)

 

To be taken concurrently with the previous treatment; one white capsule in the morning, one white/red in the afternoon and one red at night before meals, continuously for six months and re-evaluate.

Protocol 2 (Moderate Diabetes)

 

Administer 2ml daily by deep intramuscular injection for 5 days, rest 2 days and administer another complete treatment course of 2ml daily for 5 days. (Two boxes) Treatment should be repeated after 6 months.

 

Cellorgane Multi-complex tablets, take 2 tablets in the morning (on an empty stomach) and 2 tablets in the evening (on an empty stomach), concurrently with injections of Cellorgane Multi-complex. Subsequently, Treatment should be taken continuously for at least 3 months, and then re-evaluate.

 

To be taken concurrently with the previous treatment; one white capsule in the morning, one white/red in the afternoon, and one red at night before meals, continuously for six months, and then re-evaluate.

Who We Are

Biocell Ultravital™ researches and develops innovative, 100% natural, pharmaceutical-grade bioproducts, on an exclusive basis worldwide. These products optimise cell nutrition and energy, producing a preventative and curative action which, in addition to treating pre-symptoms and symptoms by means of cell renewal, refuels and corrects the cell structure of tissues and organs, preventing the appearance of the functional stress loads which give rise to poor cell formation, degenerative diseases, and their after-effects.

Policies

Product developed under pharmaceutical control according to European CE standards. Made in the EC by Biocell Laboratory France, licensed and authorized by Biocell Ultravital GmbH, Switzerland.

Privacy

This website is governed by applicable laws and government regulations. Please see our Privacy Policy.
Use of this site constitutes your consent to application of such laws and regulations.

© 2020 Biocell Ultravital